Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$210.65B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 0.86%
Avg Daily Range (30 D):	$1.02 | 0.82%
Avg Daily Range (90 D):	$1.11 | 0.87%

Institutional Daily Volume
Avg Daily Volume:	5.63M
Avg Daily Volume (30 D):	4.54M
Avg Daily Volume (90 D):	4.68M

Trade Size
Avg Trade Size (Sh.):	145
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	99,711
Avg Institutional Trade:	$5.57M
Avg Institutional Trade (30 D):	$17.01M
Avg Institutional Trade (90 D):	$15.85M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	17

Market Closing Trades
Avg Closing Trade:	$52M
Avg Closing Trade (30 D):	$145.58M
Avg Closing Trade (90 D):	$147.86M
Avg Closing Volume:	636.41K

News

Jan 20, 2026 @ 10:46 AM Week Ahead: Trade War Risks Are Back—and Ma... Source: Ali Merchant

Jan 13, 2026 @ 12:00 PM Extracorporeal Membrane Oxygenation Machine Market... Source: Sns Insider

Jan 12, 2026 @ 12:50 PM Biomedical and ICT Convergence Market Research Rep... Source: Researchandmarkets.Com

Jan 12, 2026 @ 9:10 AM Where to Invest $10,000 at the Start of This New Y... Source: Adria Cimino

Dec 27, 2025 @ 7:30 PM Is AbbVie a Buy, Sell, or Hold in 2026? Source: Prosper Junior Bakiny

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$8	$1.02	$.76
Diluted EPS	$7.97	$1.01	$.76
Revenue	$43.11B	$11.14B	$10.36B
Gross Profit	$24.15B	$6.29B	$5.89B
Net Income / Loss	$13.98B	$1.78B	$1.33B
Operating Income / Loss	$7.52B	$2.05B	$1.69B
Cost of Revenue	$18.96B	$4.85B	$4.47B
Net Cash Flow	$-64M	$368M	$-1108M
PE Ratio	15.18